Biogen Pharmachem Industries share news, announcements and annual reports
BIOGEN PHARMACHEM INDUSTRIES LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1996
Last close ₹0.25₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.25.
30 Oct: open ₹0.25, high ₹0.25, low ₹0.24
52-week range of traded prices to 30 Oct 2026
₹0.23Low, 23 Oct 2026₹0.72High, 4 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹26 Cr3,446th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 23,53,079
Biogen Pharmachem Industries board meetings
131 filed, newest first. Page 2 of 3.
Jan 2024
3 Jan · Board meeting
Meeting on 9 Jan 2024
Nov 2023
Oct 2023
26 Oct · Board meeting
Meeting on 1 Nov 2023: quarterly results
Aug 2023
3 Aug · Board meeting
Meeting on 10 Aug 2023: quarterly results
May 2023
2 May · Board meeting
Meeting on 8 May 2023: audited results
Mar 2023
22 Mar · Board meeting
Meeting on 22 Mar 2023
Feb 2023
Jan 2023
27 Jan · Board meeting
Meeting on 2 Feb 2023: quarterly results
Nov 2022
4 Nov · Board meeting
Meeting on 11 Nov 2022: quarterly results
Aug 2022
Jul 2022
28 Jul · Board meeting
Meeting on 3 Aug 2022: quarterly results
Jun 2022
13 Jun · Board meeting
Meeting on 13 Jun 2022
May 2022
19 May · Board meeting
Meeting on 25 May 2022: audited results
Feb 2022
Jan 2022
25 Jan · Board meeting
Meeting on 12 Feb 2022: quarterly results
Nov 2021
Oct 2021
28 Oct · Board meeting
Meeting on 13 Nov 2021: quarterly results
Aug 2021
4 Aug · Board meeting
Meeting on 13 Aug 2021: quarterly results
May 2021
12 May · Board meeting
Meeting on 18 May 2021: audited results
Feb 2021
1 Feb · Board meeting
Meeting on 10 Feb 2021: quarterly results
Jan 2021
6 Jan · Board meeting
Meeting on 13 Jan 2021
Oct 2020
22 Oct · Board meeting
Meeting on 30 Oct 2020: quarterly results
Aug 2020
31 Aug · Board meeting
Meeting on 7 Sep 2020: quarterly results
Jun 2020
22 Jun · Board meeting
Meeting on 24 Jun 2020: audited results